Lallemand’s L. rhamnosus HA-114 supports during a weight management program

Brunella V. Gonzales Cautela (Lallemand) discusses the impact of L. rhamnosus HA-114 on a weight loss program for people suffering of obesity and overweight.

Brunella V. Gonzalez Cautela, Clinical Research Specialist at Lallemand Health Solutions, discusses a randomized clinical trial conducted at the Université Laval in Canada to observe the impact of Lacticaseibacillus rhamnosus HA-114 on a weight loss program for participants suffering of obesity and overweight during a nutritional intervention.